Drug intelligence / Profile preview

Imupret

Development stage
Phase 4
Lead developer
Bionorica
Administration
Oral
01

Overview

Imupret is a traditional herbal medicinal product developed by Bionorica. [4, 5] It is a combination of seven plant extracts: marshmallow root, oak bark, chamomile flowers, dandelion herb, horsetail herb, yarrow herb, and walnut leaves. [1, 3, 5] Imupret is indicated for the treatment of upper respiratory tract infections such as the common cold, tonsillitis, pharyngitis, and laryngitis. [3, 4] It is used at the first signs of a cold, including a scratchy or sore throat, coughing, and difficulty swallowing. [4] The product is available as oral drops and coated tablets. [1, 6] The therapeutic rationale is based on the combined immunomodulatory, anti-inflammatory, and antiviral properties of its herbal components, which are intended to support the body's natural defense mechanisms against respiratory pathogens. [2, 6, 15]

Brand names
ImupretImupret N
Other names
Imupret N dropsImupret N sugar-coated tablets
02

Targets

IL-6 (Interleukin 6)LYZ (Lysozyme C)LTF (Lactoferrin)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Imupret.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imupret.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call